What You Should Know:
– AstraZeneca, a global biopharmaceutical company, has announced the launch of Evinova, a new business venture dedicated to providing cutting-edge digital health solutions that address the evolving needs of healthcare professionals,…
Continue Reading
UTHealth Houston’s McWilliams School of Biomedical Informatics secured over $31 million across 16 grants, predominantly from NIH divisions like NIA and NLM. These funds fuel innovative AI-driven healthcare projects, targeting Alzheimer’s treatments, clinical trial…
Continue Reading
Sabrina Steffen, Head of Data Strategy and Innovation for Data Management at IQVIA
In drug development, there is a critical focus on protocol design, because it is a key component to running a successful clinical…
Continue Reading
What You Should Know:
– AppliedVR, an immersive therapeutics pioneer, conducted a large randomized controlled trial (RCT) on virtual reality (VR) therapy for treating chronic low back pain (CLBP) at home.
– Results of the study…
Continue Reading
My phone chimed with a notification, signaling the availability of a new CT test result in my online health portal. “Multiple bilateral pulmonary nodules measuring up to 8mm. May represent metastatic disease.”
This was several…
Clinical Trial Platform Uncovers Hidden Signals and Optimizes Next Steps for More Adaptive, Successful, and Efficient Clinical Trials
PhaseV, a pioneer in causal machine learning (ML) technology that optimizes clinical trial design and analysis, announced today that it has…
GE HealthCare’s AI can accurately predict patient responses to immunotherapy, as demonstrated in collaborative studies with VUMC and UME. The models, showcasing 70-80% accuracy, may guide more personalized treatment decisions, potentially minimizing side effects…
Continue Reading
The following is a guest article by Rodman Ramezanian, Global Cloud Threat Lead at Skyhigh Security
Healthcare, like other sectors, is undergoing a massive digital transformation to meet the changing needs of patients and workers….
What You Should Know: PhaseV a pioneer in causal machine learning (ML) technology that optimizes clinical trial design and analysis, announced today that it has raised $15 million in funding, led by Viola Ventures and…
Continue Reading
We aimed to determine if a novel digital therapeutic intervention could reduce agitation and unscheduled medication use in an adult delirious acute care population. Delirious participants were randomly allocated (1:1) to receive standard of…
Continue Reading
